The fertility services market forecast is projected to grow from US$ 32.99 billion in 2023 to US$ 67.12 billion by 2031; the market is estimated to record a CAGR of 9.3% during 2023–2031.
Market Insights and Analyst View:
The factors contributing to the growing fertility services market size are the increasing accessibility and availability of healthcare facilities; growing success rates of in vitro fertilization (IVF) using ICSI in men with poor sperm morphology, motility, and low sperm count; and rising healthcare and research spending. Further, the increasing prevalence of infertility-causing medical diseases such as polycystic ovary syndrome (PCOS), endometrial tuberculosis, and sexually transmitted diseases (STDs) are also driving the market growth. Increasing awareness regarding infertility and easier access to better healthcare facilities have also increased demand for these services in developed and emerging countries. The rise in cases of infertility-related diseases has boosted the global market in recent years. Other factors contributing to the growth of the market include increasing disposable incomes, availability of flexible coverage options from health insurance companies, and increased advertising and promotion of reproductive services through television and Internet portals. Also, the report includes growth prospects in light of current fertility services market trends such as growing launches and approvals for fertility services and technological advancements.
Growth Drivers:
Increasing Prevalence of Gynecological Conditions Propels Market Growth
Tubal abnormalities such as blocked fallopian tubes, which are caused by untreated sexually transmitted diseases (STIs) or the consequences of a botched abortion, postpartum sepsis, and abdominal/pelvic surgery can lead to infertility in women. Increasing incidences of various diseases, including endometrial tuberculosis, PCOS, and STDs, that can lead to infertility drive the expansion of the fertility services market. According to the Cureus Journal published in August 2022, the global prevalence of PCOS in the female population is estimated to be between 4 and 20%. The World Health Organization (WHO) estimated that, in 2021, PCOS affected over 116 million women (3.4%) across the world. Furthermore, according to the Lancet article in 2020, the estimated number of women suffering from PCOS in China is 24 million. Thus, this factor boosts the demand for in vitro fertilization (IVF) and various assisted reproductive techniques (ART) for women, which drives the fertility services market growth.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Fertility Services Market: Strategic Insights
Market Size Value in US$ 32.99 billion in 2023 Market Size Value by US$ 67.12 billion by 2031 Growth rate CAGR of 9.3% from 2023 to 2031 Forecast Period 2023-2031 Base Year 2023
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Fertility Services Market: Strategic Insights
| Market Size Value in | US$ 32.99 billion in 2023 |
| Market Size Value by | US$ 67.12 billion by 2031 |
| Growth rate | CAGR of 9.3% from 2023 to 2031 |
| Forecast Period | 2023-2031 |
| Base Year | 2023 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Report Segmentation and Scope:
The fertility services market analysis is carried out on the basis of procedure, patient type, end user, and geography. The market, based on procedure, is segmented into assisted reproductive technology, artificial insemination, and fertility surgeries. The market, based on patient type, is bifurcated into male and female. In terms of end user, the fertility services market is segmented into fertility centers, hospitals & surgical clinics, and others.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Segmental Analysis:
Based on procedure, the fertility services market is segmented into assisted reproductive technology, artificial insemination, and fertility surgeries. The assisted reproductive technology segment accounted for the largest market share in 2023. It is expected to register the highest CAGR during 2023–2031. The market for the assisted reproductive technology segment is further segmented into in vitro fertilization, intracytoplasmic sperm injection, and surrogacy.
The fertility services market, by patient type, is bifurcated into male and female. The female segment held a larger market share in 2023. However, the male segment is anticipated to register a higher CAGR during the forecast period. The increasing stress levels, obesity, smoking, and alcohol consumption are among the factors contributing to male infertility. Furthermore, growing awareness regarding fertility services, increasing R&D expenditure, initiatives by major market players to launch their products, and changing lifestyles fuel the market growth for the male segment.
Fertility Services Market Share, by Patient Type – 2023 and 2031
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
In terms of end user, the fertility services market is segmented into fertility centers, hospitals & surgical clinics, and others. The fertility centers segment held the largest market share in 2023 and is anticipated to register the highest CAGR during 2023–2031. The increase in the number of fertility clinics worldwide, coupled with technological advancements, boosts the global market growth for this segment. In addition, awareness of infertility treatment among people in developed and emerging countries is increasing rapidly. This has led to an increased number of fertility treatment clinics worldwide, propels the global market growth for the segment. Further, increasing number of professionals who can treat infertility; growing disposable income; and upsurging number of licensed fertility clinics in developing countries such as India, China, and others also boosts the growth of the fertility centers segment.
Regional Analysis - Fertility Services Market:
The scope of the fertility services market report focuses on North America (the US, Canada, and Mexico), Europe (Spain, the UK, Germany, France, Italy, and the Rest of Europe), Asia Pacific (South Korea, China, India, Japan, Australia, and the Rest of Asia Pacific), the Middle East & Africa (South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). Asia Pacific held the largest market share in 2023 owing to introduction and rapid distribution of several infertility drugs and increasing research activities in infertility.
Europe held the third largest fertility services market share in 2023. The market in this region is segmented into Germany, the UK, Italy, Spain, France, and the Rest of Europe. The presence of numerous domestic market players and the increasing incidences of infertility are among the key factors driving the market growth in this region. Germany is one of the major contributors to the regional market. Europe hosts 40% of all IVF clinics worldwide, which has proven to be a key factor in the success of the European fertility testing and treatment market. In addition, the region has seen significant investments from global leaders. The overall outlook for the European market is promising, with superior IVF technology attracting significant investment from private equity investors. Additionally, do-it-yourself testing has increased access and helped reduce the cost of infertility testing and treatment. Both factors are expected to present lucrative opportunities for the fertility services market growth in the coming years.
The fertility services market in Asia Pacific is expected to record the fastest CAGR of XX% from 2021 to 2031. The market in APAC is segmented into China, Japan, India, Australia, South Korea, and the Rest of APAC. The market in China is growing due to rising medical tourism and improving healthcare infrastructure, which is anticipated to increase the adoption of fertility services in the region. In addition, technological advancements in developing various fertility services by the market players is expected to drive the market's growth in the region. An increase in product launches and rise in approvals for high-tech fertility services are expected to boost regional market growth in the coming years. Due to rising infertility rates in the region, a trend toward later pregnancies, increasing IVF success rates, and growing disposable income, the market in Asia Pacific is expected to grow significantly during the forecast period. IVF is one of the most commonly used methods to support people affected by infertility, including single mothers, couples, and members of the LGBT community. Furthermore, the IVF treatment market in Asia Pacific has sustainable development potential due to the upsurge in fertility tourism. Further, the market growth is expected to be fuelled by the increasing number of fertility clinics and expansion potential in emerging regions.
Industry Developments and Future Opportunities – Fertility Services Market:
According to the press releases by leading players operating in the fertility services market, a few initiatives are listed below:
- In October 2022, Indira IVF collaborated with Maven Clinic, a US-based company specializing in women's and family health with the help of telemedicine-based virtual clinics. The collaboration aims to provide Maven members in India access to Indira IVF's high-quality clinical care, other benefits, and the best virtual family education care available through the Maven platform. Indira IVF is an India-based chain of specialty infertility clinics.
- In August 2022, Genea Fertility was a Platinum Sponsor at the Australian Jewish Fertility Network's (AJFN) Annual Major Fundraiser.
- In December 2021, Cooper Surgical, a leading provider of women's health solutions, acquired Generate Life Sciences for US$1.6 billion. With this acquisition, Cooper Surgical offers an even greater selection of fertility and OB/GYN centers. Generate Life Sciences is a US-based company that provides donor eggs and sperm to fertility cryopreservation services, fertility treatment centers, and newborn stem cell storage.
- In July 2021, Hamilton Throne Ltd., a global provider of ART research, purchased IVFTECH ApS (IVFtech) and its subsidiary K4 Technology ApS. K4, IVFtech is committed to offer large-capacity laminar flow workstations and incubators for ART. The acquisition cost was US$8 million.
- In May 2021, Virtus Health, a global leader in Assisted Reproductive Services (ARS), announced a strategic collaboration with Drop Bio, an Australian biotechnology and digital health company focused on chronic inflammation, driving advances in the delivery of precision fertility.
- In February 2021, Cooper Surgical, a leading provider of women's health solutions, announced a multi-year strategic collaboration with Virtus Health, a global leader in assisted reproductive services, to drive innovation, digitalization, and advances in fertility treatment.
- In November 2020, Ferring B.V. and Igenomix entered into a research collaboration for four years to develop novel therapeutic products to treat patients affected by pregnancy-related diseases.
Competitive Landscape and Key Companies – Fertility Services Market:
CooperSurgical, Inc.; Vitrolife; Cook Medical; Care Fertility; INVO Bioscience; Carolinas Fertility Institute; Genea Limited; Merck KgaA; LABOTECT GmbH; and Monash IVF Group Limited are the prominent market players profiled in fertility services market report. These companies focus on new technologies, existing product advancements, and geographic expansions to meet the growing consumer demand worldwide.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Procedure, Patient Type, End User, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Treatments for genetic disorders and infertility problems are part of fertility services to aid conception. The development of assisted reproductive technologies (ART) such as intracytoplasmic sperm injection (ICSI) and in vitro fertilization (IVF) is one of the most significant developments in the fertility services market. These techniques have revolutionized reproductive medicine by making conceiving an embryo outside the body possible, thereby increasing the likelihood of a healthy pregnancy. Other advances include pre-implantation genetic testing, embryo cryopreservation, and egg freezing, providing additional options for couples and individuals pursuing fertility treatments.
The growing social and environmental factors and increasing prevalence of gynecological conditions contribute to the growing fertility services market size. However, high costs associated with fertility services hinder the market growth.
The fertility services market majorly consists of the players such as CooperSurgical, Inc.; Vitrolife: Cook Medical: Care Fertility: INVO Bioscience: Carolinas Fertility Institute: Genea Limited: Merck KgaA: LABOTECT GmbH: and Monash IVF Group Limited.
The fertility services market is analyzed on the basis of procedure, patient type, end user. Based on procedure, the fertility services market is segmented into assisted reproductive technology, artificial insemination, and fertility surgeries. The assisted reproductive technology segment accounted for the largest market share in 2023. It is expected to register the highest CAGR during 2023–2031. The fertility services market, by patient type, is bifurcated into male and female. The female segment held a larger market share in 2023. However, the male segment is anticipated to register a higher CAGR during the forecast period. In terms of end user, the fertility services market is segmented into fertility centers, hospitals & surgical clinics, and others. The fertility centers segment held the largest market share in 2023 and is anticipated to register the highest CAGR during 2023–2031.
The List of Companies - Fertility Services Companies
- CooperSurgical, Inc
- Vitrolife
- Cook Medical
- Care Fertility
- INVO Bioscience
- Carolinas Fertility Institute
- Genea Limited
- Merck KgaA
- LABOTECT GmbH
- Monash IVF Group Limited
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Fertility Services Market
Mar 2024
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Mar 2024
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2024
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2024
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2024
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2024
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2024
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Mar 2024
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)